PMID- 34257654 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220424 IS - 1687-8450 (Print) IS - 1687-8469 (Electronic) IS - 1687-8450 (Linking) VI - 2021 DP - 2021 TI - Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Zao-Jiao-Ci in the Treatment of LSCC. PG - 8862821 LID - 10.1155/2021/8862821 [doi] LID - 8862821 AB - OBJECTIVE: Zao-Jiao-Ci (ZJC), a traditional Chinese medicine, is considered as a promising candidate to treat laryngeal squamous cell carcinoma (LSCC). However, the underlying molecular mechanism remains unclear. METHODS: Gene expression profiles of GSE36668 were available from the GEO database, and differentially expressed genes (DEGs) of LSCC were obtained by R package; subsequently, enrichment analysis on KEGG and GO of DEGs was performed. The active ingredients of ZJC were screened from the TCMSP database, and the matched candidate targets were obtained by PharmMapper. Furthermore, we constructed protein-protein interaction (PPI) networks of DEGs and candidate targets, respectively, and we screened the core network from the merged network through combining the two PPI networks using Cytoscape 3.7.2. The key targets derived from the core network were analyzed to find out the associated KEGG signal enrichment pathway. By the GEPIA online website, Kaplan-Meier analysis was used to complete the overall survival and disease-free survival of the selected genes in the core module. RESULTS: We identified 96 candidate targets of ZJC and 86 DEGs of LSCC, the latter including 50 upregulated genes and 36 downregulated genes. DEGs were obviously enriched in the following biological functions: extracellular structure organization, the extracellular matrix organization, and endodermal cell differentiation. The 60 key targets from the core network were enriched in the signal pathways including transcriptional misregulation cancer, cell cycle, and so on. We found that LSCC patients with high expression of HIST1H3J, HIST1H3F, and ITGA4 had worse overall survival, while higher expression of NTRK1, COPS5, HIST1H3A, and HIST1H3G had significantly worse disease-free survival. CONCLUSION: It suggested that the interaction between ZJC and LSCC was related to the signal pathways of transcriptional misregulation cancer and cell cycle, revealing that it may be the mechanism of ZJC in the treatment of LSCC. CI - Copyright (c) 2021 Feng Xiang et al. FAU - Xiang, Feng AU - Xiang F AUID- ORCID: 0000-0002-3780-020X AD - Department of Otolaryngology, YangZhou Hospital of Traditional Chinese Medicine, JiangSu, YangZhou, China. FAU - Li, Linman AU - Li L AUID- ORCID: 0000-0002-8595-9434 AD - The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Lin, Jieling AU - Lin J AUID- ORCID: 0000-0002-1643-7421 AD - The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Li, Shasha AU - Li S AUID- ORCID: 0000-0003-1170-4591 AD - The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. FAU - Peng, Guiyuan AU - Peng G AUID- ORCID: 0000-0003-3873-0845 AD - Department of Otolaryngology, Guangdong Province Hospital of Chinese Medicine, Guangzhou, Guangdong, China. LA - eng PT - Journal Article DEP - 20210625 PL - Egypt TA - J Oncol JT - Journal of oncology JID - 101496537 PMC - PMC8257394 COIS- The authors declare that they have no conflicts of interest. EDAT- 2021/07/15 06:00 MHDA- 2021/07/15 06:01 PMCR- 2021/06/25 CRDT- 2021/07/14 07:02 PHST- 2020/09/10 00:00 [received] PHST- 2021/06/08 00:00 [accepted] PHST- 2021/07/14 07:02 [entrez] PHST- 2021/07/15 06:00 [pubmed] PHST- 2021/07/15 06:01 [medline] PHST- 2021/06/25 00:00 [pmc-release] AID - 10.1155/2021/8862821 [doi] PST - epublish SO - J Oncol. 2021 Jun 25;2021:8862821. doi: 10.1155/2021/8862821. eCollection 2021.